DeviceTalks News

Academic, incubator leaders share how and where innovation is surviving and thriving during COVID-19

Academic, incubator leaders share how and where innovation is surviving and thriving during COVID-19

Coming Soon

Digging into the Digital Medtech & Surgical Worlds with Mark Toland, Scott Huennekens, and Kal Patel

Digging into the Digital Medtech & Surgical Worlds with Mark Toland, Scott Huennekens, and Kal Patel

This week we’ll dig deep into digital surgery, robotics and the power of THE CLOUD.

In our opening keynote conversation, Mark Toland, CEO of Medical Micro Instruments, explains why the company’s microsurgical robot has a chance to be in most hospitals. The company has CE Mark, a controlled commercial roll out and plans to knock in the FDA’s door sometime in 2022 where it will face huge competition (or, we think, potential acquirers if history holds out.) Watch the cool CNBC video here.

Next, we talk with Scott “Go Go Go” Huennekens, employee number 1 at the former Verb Surgical, about the state of digital medtech. Huennekens, who previously led and sold Volcano Corp., explains why you can no longer have the latter without the former. Kal Patel, CEO of BrightInsight, explains why medtech must follow a different path – with equally unique challenges – to fully enjoy the power of digital connection.

Danielle Kirsh, senior editor of Mass Device, drops by to bring us up to date at two cool devices presented at CES 2001. You can read about Omron and Binah.ai here.

Finally, Co-hosts Tom Salemi and Chris Newmarker walk through this week’s #NewmarkersNewsmakers featuring news from Abbott, Steris, Cantel and Theranos.

Medtronic’s Kowal on remote tech’s rebirth, SVB’s Norris delivers good news for VCs, CEOs

Medtronic’s Kowal on remote tech’s rebirth, SVB’s Norris delivers good news for VCs, CEOs

Dr. Robert Kowal, CMO of Medtronic’s cardiac rhythm and heart failure business and vice president of medical affairs, explains how new tech, savvy patients, eager physicians and, yes, COVID-19, has fueled a renaissance for remote technology, once seen as a mature, staid business. Dr. Kowal also shares an amazing story of a patient who may owe his life to a timely conversation between his pacemaker and cellphone.

Jon Norris, managing director of healthcare at Silicon Valley Bank, delivers three big takeaways from his report on 2020 fundraising. Medtech venture capitalists and start-ups didn’t let the lockdown slow their fund-raising efforts, and their efforts were buoyed by surprising strong exiting opportunities through IPOs and M&A.

Co-hosts Chris Newmarker and Tom Salemi review the medtech industry’s response to the riot and occupation of the Capitol building. This week’s #NewmarkersNewsmakers includes news from Smith & Nephew, Stryker, and the disappearing Haven.

Taking the fight to COVID-19 - BD, DHL, Novant on delivering, shipping and administering the vaccine

Taking the fight to COVID-19 - BD, DHL, Novant on delivering, shipping and administering the vaccine

Happy Vaccine Week!

This week, we’ll visit with the medtech professionals who are working to get the vaccines into the right hands – and arms – of the people who need it most.

This week’s guests include

  • Elizabeth Woody, Senior Vice President, Public Affairs at BD
  • Claudia Roa, Vice President Life Science & Healthcare Sector, Americas Global Customer Solutions at DHL
  • Eric Eskioğlu, MD, EVP & Chief Medical Officer, Novant Health

Co-hosts Tom Salemi and Chris Newmarker welcome Brian Buntz, medtech pro and now pharma editor at WTWH Media, for a recap of the top 10 #newmarkersnewsmakers of 2020.

We also look ahead to 2021 offering our Big, Bold Predictions for the New Year. (And someone offers to pick up the first round of drinks at DeviceTalks Boston in October…well, sort of.)

This is the final episode of the DeviceTalks Weekly Podcast for 2020! Thanks to the tens of thousands (yep, really) people who have joined us on this audio journey.

We’ll be back in January with a new DeviceTalks Weekly Podcast. Subscribe now so you don’t miss it!

Stryker CEO Kevin Lobo shares successful strategies for managing multiple crises (aka life in 2020)

Stryker CEO Kevin Lobo shares successful strategies for managing multiple crises (aka life in 2020)

The past year of pandemic, social unrest and a divisive election – provided a crash course in crisis management for CEOs. In this week’s DeviceTalks Weekly Podcast, Kevin Lobo, the CEO of Stryker, explains how he led his company through this difficult year.

His recipe for success is long, but it includes priorities, communication and listening.

Lobo also is serving his final year as chairman of AdvaMed. He shares how that experience gave him an even better appreciation of the medtech industry, which he says got treated unfairly at times but still came through with high grades.

Joining us for the first time as a co-host is Nancy Crotti, managing editor of Medical Design and Outsourcing. She’ll talk about the upcoming leadership issue.

Meanwhile, Sean Whooley, assistant editor of MassDevice, will share the five big news items of the week aka #NewmarkersNewsmakers. This week’s news comes from Quest, Pfizer, Boston Scientific and Medtronic.

And we’ll learn which co-host had a steak cooked for them by a future president of the United States.

Medtronic CEO Martha explains the why of competing, the reorg, and the importance of institutions

Medtronic CEO Martha explains the why of competing, the reorg, and the importance of institutions

In this episode of the DeviceTalks Weekly Podcast, Medtronic CEO Geoff Martha brings us on the inside of Medtronic’s ongoing reorganization. Martha explains how the new company will be structured to work with outside vendors. (Hint: more autonomy, not total autonomy.)

He also explains why the company’s push to instill more competitive juice is aligned with its overarching mission of innovation.

Martha also discussed his long path to medtech and Medtronic. How he first met Omar Ishrak and why institutions like Medtronic and other medtech companies need to step up on a social scale.

This week, Dave Franchino, president of Delve, explains how the company is adapting innovation to fit the pandemic. (And suggests if you’re not finding opportunities to innovate, you’re simply not looking hard enough.)

But there is no DeviceTalks party without Chris Newmarker, executive editor of MassDevice, who shares this episode’s Newmarker Newsmakers. Companies covered include Medtronic, Vectorious Medical Technologies, GE Healthcare, Stryker and Butterfly Network.

Subscribe today you major podcast platforms!

Enjoy a feast of insights from Spencer Stiles(Stryker) Art Collins(Explorer) and Mark Leahey (MDMA)

Enjoy a feast of insights from Spencer Stiles(Stryker) Art Collins(Explorer) and Mark Leahey (MDMA)

DeviceTalks Weekly listeners will need some gravy to digest this Thanksgiving feast-sized podcast featuring news and insights from three stellar guests in addition to two new installments of #2minutedetalks chapters from Delve Inc. and Explorer Surgical.

This week we visit with…

Mark Leahey, president of the Medical Device Manufacturers Association, who explains where medtech might fits in this evolving political climate.
Spencer Stiles, group president of orthopaedic and spine at Stryker, who shares details on the Wright acquisition and the secret to the success of placing MAKO surgical robots in hospitals
Art Collins, senior advisor to Explorer Surgical. The former Chairman and CEO discusses leadership, Medtronic and the future for startups like Explorer.

Also co-host Chris Newmarker, executive editor of MassDevice, shares his selections for this week’s #newmarkersnewsmakers which includes news from BD, Boston Scientific and Johnson & Johnson.

Vizient, Truist on how COVID-19 has changed healthcare’s appetite for buying medical devices

Vizient, Truist on how COVID-19 has changed healthcare’s appetite for buying medical devices

This week’s DeviceTalks Weekly Podcast examines medtech’s readiness for the next COVID-19 surge.

Hospitals are ready, but their appetite for expensive medical devices has changed, forcing medtech companies to change how they sell or lose out entirely.

Justin Cassidy and Henry Soch of Vizient reveal why hospital executives are forced to divert funds away from new devices. They also explain how the power structure in capital purchases is shifting away from technology committees, creating a new challenge for medtech sales teams.

Kaila Krum, managing director of Truist Securities, explains how companies like Stryker, Zimmer Biomet and Globus are successfully putting units in hospitals. She confirms medtech companies are being forced to evolve the way they work with hospitals.

In the 2-minute-DeTalks, product development leader, podcast and president of Delve Dave Franchino joins us in a 2minute-detalks to explain how the company helps clients find the best solution to vexing problem. (Delve.com.)

Explorer Surgical CEO Jennifer Fried makes the case for how her innovative start-ups tech company’s will not only connect surgeons with remote sales reps but also giving a broader view of how successful teams function.

Chris Newmarker, executive editor of MassDevice, reveals his #NewmarkersNewsmakers highlighting contributions by Abbott, Stryker, Joe Biden, and EU-MDR.

Where will Intuitive find future growth? Abbott’s Moat on how population boom will boost demand

Where will Intuitive find future growth? Abbott’s Moat on how population boom will boost demand

In this episode of the DeviceTalks Weekly Podcast, we’ll talk with Intuitive Surgical’s Julian Nikolchev, senior vice president, corporate development and strategy and Oliver Keown, MD, director of Intuitive Ventures, about the new $100 million venture fund. How will the capital be invested? Where does Intuitive see the opportunity, and how does the program fit into the robotic surgical company’s broader mandate to expand the profile of its product offerings? In our opening keynote, Neal Moat, MD, chief medical officer of Abbott’s structural heart business, talks about the success of the MitraClip and the impact COVID-19 is having on patients and Abbott personnel.

Chris Newmarker, executive editor of MassDevice, will roll out his Newmarker’s Newsmakers including news about Abbott, Masimo and Stryker. Sean Whooley, assistant editor, will also give an earning wrap on the show highlighting interesting reports from Inspire Medical, Hologic, Stryker and Coloplast.

DeviceTalks listeners are also invited to nominate their own Newmarker’s Newsmakers of 2020. Use this online ballot to make your suggestions. We’ll send out a ballot of the finalists later this month.

Go to www.surveymonkey.com/r/MWDPVKD to vote!

Subscribe today to receive future podcasts!

Hear from Execs Katie Szyman, Naomi Murray, Start-Up CEO Patty Post & Evercore’s Vijay Kumar

Hear from Execs Katie Szyman, Naomi Murray, Start-Up CEO Patty Post & Evercore’s Vijay Kumar

In this week’s episode of DeviceTalks Weekly the editorial team from MassDevice reviews the Medical Design & Outsourcing’s Women in Medtech issue bringing you insights through interviews with Katie Syzman, corporate VP and the GM of critical care at Edwards Lifesciences, Naomi Murray, Stryker’s director of advanced operations, and Patty Post, CEO of Startup Checkable Medical.

Szyman will share Edwards’ view of artificial intelligence. Murray will share her future vision on additive manufacturing while Post will reveal the lessons learned in her first post as startup CEO of a diagnostic company.

In our closing keynote conversation, Vijay Kumar, managing director at Evercore ISI, will explain why Exact Science’s acquisition of liquid biopsy company wasn’t exactly a surprise (though the $2 billion pricetag might have been.) He also assesses Boston Scientific’s COVID-19 comeback. What does the rise in cases mean for the company and the rest of medtech?

Chris Newmarker, executive editor of life sciences, delivers this week’s Newmarker’s Newsmakers which highlights reports on Abbott, Baxter, Intuitive Surgical and Siemens. Senior Editor Danielle Kirsh also is on hand to talk through MassDevice Big 100 report. Assistant editor Sean Whooley also joins the conversation.

Philips' Imaged Guided leader Landon shares global giant's plans for minimally invasive devices

Philips' Imaged Guided leader Landon shares global giant's plans for minimally invasive devices

In this week’s DeviceTalks Weekly podcast, we visit with Chris Landon, senior vice president and business leader of image guided therapy devices at Philips about that company’s plans to build a medtech powerhouse.

In this conversation we’ll learn

  • Why Landon left Medtronic
  • Where Philips fits into medtech’s future
  • How Philips hopes to expand
  • Will Philips invest directly in start-ups?
  • How did Covid-19 impact Philips?

We’ll also get Landon’s stance on pumpkin sausages. Disgusting or delicious?

We also welcome back Chris Newmarker, executive editor of Mass Device, who delivers his Newmarker’s Newsmakers including news from GE Healthcare, Merit Medical, Pharma, Eurofins (Paris:ERF.PA) and DxTerity Diagnostics and the FDA

Subscribe today on your podcast apps!

Who will win medtech’s own Supreme Court fight; and can the many mini Medtronics plan work?

Who will win medtech’s own Supreme Court fight; and can the many mini Medtronics plan work?

In this week’s DeviceTalks Weekly podcast, we’ll first delve into Medtech’s own brewing Supreme Court battle. In our opening keynote address sponsored by Medical Design and Outsourcing, J. Michael Jakes, a partner at Finnegan, will tell us why the industry should be watching when the Supremes review the latest patent battle between Arthrex and Smith & Nephew.

We’ll also talk about Medtronic’s Analyst Meeting where CEO Geoff Martha and the team rolled out its decentralization plan that calls for the creation of 20 semi-independent business units. Kaila Krum, managing director at Truist Securities, returns to break down the highlight of the meetings including pipelines and partnership with The Foundry, Amazon and others.

Sean Whooley, assistant editor at Mass Device, pinch hosts for the vacationing Chris Newmarker and delivered with a rock solid #newmarkersnewsmakers that includes news from Abbott, Arthrex, Smith & Nephew, GE, and, of course, Medtronic.

Smith & Nephew's Ortho President Kiil, Rhaeos CEO Somera's Big Win, and Medtronic's Legacy

Smith & Nephew's Ortho President Kiil, Rhaeos CEO Somera's Big Win, and Medtronic's Legacy

In this week’s DeviceTalks Weekly Podcast, our opening and closing keynote interviews focus on executives at companies from very different stages.

MANUFACTURING AND SOURCING: Skip Kiil took the helm of Smith + Nephew’s global orthopedics business to transform the business. The company’s recent acquisition of Integra’s extremities will further that mission. In our closing keynote conversation, the president of orthopedics updates us on the new technologies and tools that Smith + Nephew is rolling out to help orthopedic patients.

Kiil will hit upon Smith + Nephew’s:

  • CORI Robotics surgical tools
  • Real Intelligence platform
  • Interest in Ambulatory Surgery Centers
  • Balance of OUS vs. US
  • Future plans for extremities

INNOVATION AND FINANCE: Start-up Rhaeos took home this year’s Grand Prize from the Medtech Innovator Global Competition at the Virtual Medtech Conference. In our 0pening keynote, CEO Anna Lisa Somera tells us why she went “all in” on developing a hydrocephalus wearable device that can help this suffering patient population.

Somera will discuss:

  • Winning the Global Competition
  • The power of Rhaeous’ wearable technology
  • Medtech’s ability to help long suffering patients
  • The start-up’s fundraising plans.

Co-hosts Tom Salemi and Chris Newmarker will also review this week’s biggest stories on MassDevice including former Medtronic CEO Omar Ishrak’s legacy, current Medtronic CEO Geoff Martha’s optimism, and Avail Medsystem’s $100 million plans to grow procedural telemedicine.

Avail Medsystems, AliveCor help surgeons, patients, and sales reps battle COVID through connectivity

Avail Medsystems, AliveCor help surgeons, patients, and sales reps battle COVID through connectivity

Medtech People: In this week’s DeviceTalks Weekly Podcast, we’ll talk about overcoming unfairness and inequity.

In a double dose of New Tools and Technology interviews, co-host Tom Salemi talks with two companies using connective technology to build out innovative service businesses.

Medtech veteran Daniel Hawkins, CEO of Avail Medsystems, creator of a procedural telemedicine system that can open up the operating room for sales reps and surgical experts. Hawkins explains how Avail will provide the equipment to hospitals for free while creating new channels for medical device companies to advise surgeons in the operating room. You can learn more about Avail’s approach on our upcoming DeviceTalks Tuesday episode on Oct. 6.

In our opening interview, Ira Bahr, COO of AliveCor, explains how the company’s AI-enabled, consumer EKG device, KardiaMobile 6L, is connecting heart patient with their physicians. The company is selling the device for patient monitoring both in home and clinical trial settings. How will tech like this open the the clinical trial market. Also, learn how AliveCor is shifting into more of a service company.

Meanwhile, co-cost Chris Newmarker, executive editor of life sciences at MassDevice, is off the the races with his #NewmarkersNewsmakers which includes BD, Boston Scientific, Coloplast, Medtronic and Smith+Nephew.

Can Boston Scientific Close the Gap in healthcare? Innovator Jeff Karp, MD, shares early challenges

Can Boston Scientific Close the Gap in healthcare? Innovator Jeff Karp, MD, shares early challenges

Medtech People: In this week’s DeviceTalks Weekly Podcast, we’ll talk about overcoming unfairness and inequity.

In our keynote interview, Boston Scientific’s Camille Chang Gilmore, vice president, human resources, global chief diversity officer, and Michael Jaff, MD, CMO of its peripheral vascular group, reintroduce us to the company’s Close the Gap program. Launched in 2006, Close the Gap seeks to address the lack of care being delivered to underserved populations, including people of color and people earning lower incomes. The two Boston Science executives will explain why Close the Gap is more essential than ever, and what we as an industry need to do to bring equality to care. Go to knowyourhealth.com for more information.

In our first interview, Jeff Karp, MD, a prolific inventor and entrepreneur, shares his early challenges as a child when a learning difference limited his performance in school. After hearing some stern advice from teachers, Karp identified the problem and explained how overcoming his challenges gave him the ability to see innovative ways to solve problems. Go to devicetalks.com to see the rest of the Device Talks Tuesday interview from Sept. 22. www.devicetalks.com/devicetalks-tue…emand-sessions/

And, of course, Chris Newmarker, executive editor of MassDevice, runs us through Newmarker’s Newsmakers, the top 5 performing articles on MassDevice. Subjects include Boston Scientific, Farapulse, the FDA, and NanoVibronix.

Outset CEO Leslie Trigg discusses Zoom-powered $278m IPO; Corindus COO Doug Teany sees 5G future

Outset CEO Leslie Trigg discusses Zoom-powered $278m IPO; Corindus COO Doug Teany sees 5G future

INNOVATION & FINANCE: Is the traditional road show dead? Leslie Trigg, CEO of Outset Medical, fresh off taking the renal care company public, says despite initially grieving her inability to meet investors in person, she agrees that Zoom meetings gave her all the insights she needed to stage a successful IPO. In fact, she says the video calls might have even engendered a deeper understanding between executives and investors. Trigg also explains how Outset came to broaden its overall mission to create an enterprise system for dialysis.

NEW TOOLS & TECHNOLOGY: The doctor will see you now … from 3,000 miles away. Doug Teany, COO of Corindus Vascular Robotics, says the company’s Corpath interventional robotic system will save lives and money by shortening the distance between critical patients and capable care. Using the emerging 5G network, Corindus is moving toward a future where interventionalists can treat patients in different area codes, time zones and countries. The company is profiled in a 5G documentary called “Speed of Thought.” Check it out on Amazon Prime and other channels.

Finally, the week wouldn’t be complete with Chris Newmarker, executive editor of MassDevice, revealing this week’s #Newmarkersnewsmakers featuring news from Hologic, Varian, Smith & Nephew, and Outset Medical.

Ambu, Boston Scientific in the first single-use DeviceTalks Weekly– No sterilization necessary

Ambu, Boston Scientific in the first single-use DeviceTalks Weekly– No sterilization necessary

MANUFACTURING & SOURCING: This week, the DeviceTalks Weekly Podcast explores the potential of single-use endoscopes. Co-host Tom Salemi interviews leaders from the leaders – Ambu and Boston Scientific. First, Ambu CEO Juan Jose Gonzalez and Stephen Block, president of Ambu US, introduce us to one of medtech’s fastest growing companies. Ambu is moving into the single-use market with a less expensive alternative to those offered by larger rival Boston Scientific. We’ll find how Gonzalez and Block view the opportunity. In our second interview, we dig into the EXALT offering with Boston Scientific’s CMO Brian Dunkin, MD and Dave Pierce, EVP and President MedSurg. After a slow start due to COVID-19 shutdowns, Boston Scientific is putting the pedal to the metal by leveraging its extensive reach and might. Executives from both companies share why they can’t see the ceiling to the potential of this technology.

MassDevice’s Executive Editor Chris Newmarker will reveal this week’s #NewmarkersNewsmakers including Bardy Diagnostics, Kevin Hykes, COVID-19 Vaccine makers, Theranica, Joe Biden, Donald Trump and Theranos founder Elizabeth Holmes.

Raising Capital during Covid with Karen Long; Gail Daubert on CMS changes, Are linked pigs scary?

Raising Capital during Covid with Karen Long; Gail Daubert on CMS changes, Are linked pigs scary?

Our line up in Episode 25 of the DeviceTalks Weekly Podcast:

INNOVATION & FINANCE – Managing Partner Karen Long says COVID-19 isn’t slowing down KCK Group, which closed on two major investments this summer. Long will be speaking on our first DeviceTalks Tuesday’s “Raising Capital in the Zoom Age.” Go to devicetalks.com.

REGULATORY & REIMBURSEMENT – Gail Daubert, founding partner at 4Front Strategies walks us through the proposed CMS rule to pay for innovative breakthrough technologies. Daubert suggests industry leaders offer their feedback on the proposed rule. For information on submitting feed back go to www.federalregister.gov/documents/202…easonable-and

NEWMARKER’S NEWSMAKERS – Chris Newmarker, executive editor of life sciences at MassDevice, reports on the five biggest Medtech newsmakers. Items involve Medtronic, IBM, Elon Musk, and CMS.

Truist’s Kaila Krum on Medtronic’s Q1, APVC’s Juan Pablo Mas details new investment in Exo

Truist’s Kaila Krum on Medtronic’s Q1, APVC’s Juan Pablo Mas details new investment in Exo

In this week’s DeviceTalks Weekly Podcast, Kaila Krum, managing director at Truist Securities, explains why Medtronic is talking tough about finding new growth. Can the medtech giant pull off CEO Geoff Martha’s pledge to `Go Big or Go Home.”

Juan-Pablo Mas, partner at Action Potential Venture Capital, lends insights on his group’s commitment to EXO (pronounced echo), a maker of a portable ultrasound imaging device that might have somewhat unforeseen therapeutic applications. He also shares his hopes for LatinxVC, a non-profit creating opportunities in venture capital.

Senior Editor Danielle Kirsh and Assistant Editor Sean Whooley pinch hit for Chris Newmarker. Kirsh lays out her plans for this year’s Women in Medtech issue and Whooley walks us through this week’s Top 5 stories (aka Newmarker’s Newsmakers.) Medtronic, Abbott, Boston Scientific, Pelvital, and iRhythm all make the list. But who is number 1?

Can Fractyl Labs and Cala Health go where only drugs have gone before?

Can Fractyl Labs and Cala Health go where only drugs have gone before?

In this week’s DeviceTalks Weekly podcast, co-costs Tom Salemi and Chris Newmarker walk through this week’s “Newmarker’s Newsmakers,” the Top Five #medtech stories of the week with news coming from CureVac, Avail Medsystems, ClearMask, Thermo Fisher and Bayer.

We also hear from CEO Harith Rajagopalan, MD and CFO Lisa Davidson of Fractyl Laboratories, which is making great strides in developing a device to treat diabetes.

Cala Health CEO Renee Ryan returns to the podcast to give us an update on the Cala Trio’s clinical success in reducing essential tremors and how the start-up is working through COVID-19.

Finally, Chris and Tom hint at an upcoming event for the DTW community.

Subscribe today on Apple Podcasts, Spotify, and other players.

Vizient on PPE, Vicarious on VR-aided robotics and let’s all hope for pumpernickel

Vizient on PPE, Vicarious on VR-aided robotics and let’s all hope for pumpernickel

This week’s episode of DeviceTalks Weekly is brought to you by the later V, as in Vizient and Vicarious Surgical.

Bharat Sundaram, COO and president of Vizient, will share how the healthcare supplier is strengthening the supply of PPE for hospitals. He’ll also reveal when the company expects to see US hospitals running at pre-Covid levels. Hint, it’ll be a while.

Adam Sachs, CEO of Vicarious Surgical, tells us how the company will put a new round of capital from high-powered investors including Bill Gates and Vinod Khosla to work in developing to develop a surgical system employing robotic and virtual reality technologies. How does the start-up expect to compete with the established leaders in the robotics space?

Co-host Chris Newmarker, executive editor, life sciences, will walk us through the five biggest newsmakers on the MassDevice site involving C.R. Bard, Theranos, and Medtronic. Number one may surprise you, but given the time, perhaps it shouldn’t.

Subscribe to the podcast on Apple Podcasts, Spotify and other players!

10 ways medtech is finding its footing amid COVID-19

10 ways medtech is finding its footing amid COVID-19

When COVID-19 set upon the U.S. in March, medtech executives had a month at most to tell Wall Street analysts how the pandemic had hit the industry’s largest companies. We heard about short-term hits in revenues, procedures and employee headcounts, but uncertainty clearly ruled the day.

Over the past few weeks, medtech executives from several leading companies reported back to analysts with a full quarter under their belt. To be sure, no one can claim to hold a full grasp on this crisis, but a survey of the calls reveals steps and adjustments that companies are taking to thrive beyond the pandemic.

In this podcast, we’ll list our Top 10.

What in the world will Thrive Earlier Detection do with $257 million?

What in the world will Thrive Earlier Detection do with $257 million?

In this week’s podcast, two executives from Thrive Earlier Detection explain how the “turbo-charged” diagnostics company intends to upend how, when and where cancer is diagnosed. Isaac Kinde, MD, PhD, co-founder and head of research and innovation, walks us through the company’s CancerSEEK test and how the company is marrying new technology with an innovative clinical approach. Meanwhile, Isaac Ro, tells host Tom Salemi how the company closed on $257 million (hint: lots of Zoom) and why he left a career on Wall Street to join this innovative start-up.

Chris Newmarker, executive editor of life sciences at MassDevice, also counts down on the biggest newsmakers in this week’s MassDevice.

Don’t miss an episode! Subscribe to DeviceTalks Weekly on your podcast players. It’s available on Apple Podcasts, Spotify and other podcast channels.

Can Drawbridge, Edwards bring disruptive innovation to blood drawing, heart surgery industries?

Can Drawbridge, Edwards bring disruptive innovation to blood drawing, heart surgery industries?

In this week’s podcast, we talk with Holly Logue, general counsel at Drawbridge Health, about the OneDraw, an innovative new tool that might upend the collecting, storage and testing of blood. Logue, a panelist in the upcoming DeviceTalks Tuesdays sponsored by Finnegan, will explain how her past work on Capitol Hill is helping this Silicon Valley company’s plans.

Meanwhile, we speak with Daveen Chopra, corporate vice president of surgical structural heart at Edwards Lifesciences, about that company’s commitment to treating the most serious cardiac patients. The company recently won FDA approval for its Konect Resilia aortic valve conduit, a vital new tool in helping heart patients, including many requiring emergency story.

Co-costs Tom Salemi, editorial director of DeviceTalks, and Chris Newmarker, executive editor of life sciences at MassDevice, review the five biggest news stories of the week. We’ll talk about Abbott, Becton Dickinson, Boston Scientific, Edwards Lifesciences, and Theranos. Number one may surprise you.

Is Medtech finally ready to capitalize on the promise of connectivity?

Is Medtech finally ready to capitalize on the promise of connectivity?

Twenty years ago, David Hayes, MD, then a cardiologist at the Mayo Clinic, shot down the idea that medical devices would serve patients better if equipped with technology that collected and transmitted data.

Hayes had many reasons. He said patients liked coming to the doctors’ offices. “I thought they’d miss that connection,” he said. He worried that physicians would be overwhelmed with too much data. He had other objections too. And he’s not afraid to admit – “You could just check them off one-by-one,” he said in this week’s DeviceTalks Weekly podcast. “I was wrong on every one.”

Hayes, now chief medical officer for Biotronik, came around years ago and now he’s responsible for ensuring the medical device company keeps moving forward in incorporating technology that can connected patients with physicians and hospitals. Biotronik is among the growing number of medical device companies that are examining new potential for medtech connectivity.

The march toward medtech connectivity was already inevitable. According to a report issued by S3 Connected Health, the global market for connected medical devices will triple over the next four years hitting $188 billion in 2024. The report estimates that 50 billion medical devices will connect clinicians, health systems, patients and other devices over the next decade.

COVID-19’s impact on the healthcare system only accelerated the adoption. Medtech veteran Bill Betten, director of medtech solutions, at S3, said many medtech startups worked hard to pivot their products to service the COVID-19 market. For example, hearing aid makers incorporate new technology in their process to allow patients to be fitted for devices without having to visit an audiologist, Betten said in the podcast.

Hayes, the Biotronik CMO, says his company similarly will let technology do more of the heavily lifting in monitoring patients who have received pacemakers and other implants. Hayes says historically Biotronik’s patients would come in for in-person check ups on a fairly routine basis. But closer study shows those visits don’t require any treatment or action by the physicians. “I believe what this will drive us to do is more of those routine non-actional checks remotely and we’ll only bring people in when there’s a suspicion that we need to actively do something,” Hayes said.

Betten, who will be a speaker on the DeviceTalks Tuesdays event, says quicker adoption of new connectivity technology is possible if payers and regulators don’t tighten the rules that have been relaxed to accommodate remote patient care during the pandemic. Medtech companies, big and small, would be wise to have connectivity plans in place to position their device to operate fully in a changing landscape, he told the podcast..

To find out more information about the DeviceTalks Tuesday discussion go to DeviceTalks.com.

CVRx Nadim Yared on COVID-19, diversity and equality; Hyalex CEO Mira Sahney shares startup details

CVRx Nadim Yared on COVID-19, diversity and equality; Hyalex CEO Mira Sahney shares startup details

In part 2 of an interview, we follow up with last week’s guest, CVRx CEO Nadim Yared, to catch up on how the medtech executive is managing during the pandemic.

Yared also shares some far-reaching views on what the medtech industry needs to work toward to improve diversity in its workforce and provide equality for society.

We also visit with Mira Sahney, CEO of Hyalex Orthopaedics, one of medtech’s most interesting startups. Hyalex was identified as a notable startup in this recent report in Medical Design and Outsourcing.

In this interview, Sahney reveals Hyalex’ origins, the state of its potential cartilage replacement product, and why start-ups have a natural advantage operating in a pandemic.

Don’t miss an episode! Subscribe to DeviceTalks Weekly on your podcast players.

 

CVRx CEO Nadim Yared on his path from engineer to CEO to industry leader.

CVRx CEO Nadim Yared on his path from engineer to CEO to industry leader.

This week, CVRX reported positive six-month trial results for its Barostim Neo, an FDA-approved treatment for heart failure.

The results follow years of close work between the agency and CVRx, one of the more ambitious startups in medtech. CVRx is targeting a huge clinical need with novel neuromodulation technology.

In this week’s DeviceTalks Weekly podcast, CEO Nadim Yared walks us through the negotiations the company went through with the FDA to get to this point.

 

Yared, the prior chairman of the industry group AdvaMed, also shares the story of his career, which started early on when he secured a job at GE even before graduating college.

In this talk, Yared speaks to several issues including:

  • The power of confidence and the dangers of overconfidence when building a career.
  • How he decided to take the job at CVRx (and why he didn’t initially want to talk about the job with a recruiter.)
  • What CVRx learned from other successes and failures in renal denervation.
  • Why the company is betting big on heart failure, but doesn’t have a Chief Medical Officer.
  • Whether or not his role as chairman at AdvaMed impacted his work at CVRx.
  • Can medtechs generate good returns after raising hundreds of millions in capital?

 

This conversation took place prior to the emergence of COVID-19, so DTW host Tom Salemi visited again with Yared more recently. We’ll play that interview in next week’s episode of DeviceTalks Weekly.

If you’re looking for more medtech discussions, register now for DeviceTalks Tuesday at devicetalks.com.

Subscribe to the podcast. Don’t miss an episode!

Why FDA put the pedal to the metal for radar and hummingbirds. And why medtech needs Google.

Why FDA put the pedal to the metal for radar and hummingbirds. And why medtech needs Google.

In this week’s episode of DeviceTalks Weekly, co-hosts Chris Newmarker and Tom Salemi dig into the recent successes by start-ups Circadia Health and Perceptis Medical, which both saw expedited approval from the FDA due to the pandemic.

We also unveil the 20 medical device companies you need to know.

Circadia CEO Fares Siddiqui discusses the quick approval that came for his company’s C100 system that uses radar to monitor respiratory function. Preceptis Medical CEO Steve Anderson, meanwhile, explains why the agency – and he hopes payers – want to see his company’s ear-tube implanting system on the market.

We also visit with Heidi Dohse, Sr. Program Manager at Google’s Cloud Healthcare & Life Sciences organization, who will be leading the upcoming DeviceTalks Tuesday’s discussion about how medtech devices can use data to better serve its sickest patients.

Dohse partners with physicians and researchers around the world to provide insights regarding the patient experience and ideas for engagement. She travels globally educating audiences on digital health, data and healthcare. On Tuesday, she’ll discuss.

  • How do we weigh “patient lifestyles” vs. “therapy/product” lifecycles”?
  • What impact will connected devices and apps have on patient outcomes?
  • How can data help improve and even transform the patient experience?

Don’t miss an episode! Subscribe to DeviceTalks Weekly on your podcast players.

Stryker’s Kevin Lobo, Dexcom’s Kevin Sayer talk diversity, COVID-19; also more on Medtronic deal

Stryker’s Kevin Lobo, Dexcom’s Kevin Sayer talk diversity, COVID-19; also more on Medtronic deal

 

This podcast is sponsored by maxon.

This week’s DeviceTalks Weekly podcast episode talks with industry leaders about improving worker diversity and developing new ways to treat COVID-19 patients.

Kevin Lobo, chairman and CEO of Stryker, explains how his company – and the industry group AdvaMed – has been working to increase diversity of its workforce, particularly in senior and sales positions. Lobo is serving a two-year term as chairman of AdvaMed. In this interview, Lobo speaks specifically to how Stryker is tracking progress, where it has come up short, and how it’s working to help workers identify their own biases.

Lobo also says Stryker is poised to regain momentum after the pandemic.

Next, Kevin Sayer, executive chairman, CEO and president of Dexcom, says the company’s continuous glucose monitors are finding a home in hospitals as they help monitor the health of COVID-19 patients. Sayer says the company’s monitors have helped keep patients, especially diabetics, off ventilators and allowed them to get discharged more quickly. What’s next for Dexcom? “We think this is an important market for us, not just COVID-wise,” Sayer says.

Finally, Raj Denhoy, equity research analyst at Jefferies, breaks down private equity group Blackstone’s investment in Medtronic’s diabetes line. Why would the medtech giant take outside money? Is this something we’ll see more of in medtech?

Don’t miss an episode! Subscribe to DeviceTalks Weekly on your podcast players.

DeviceTalks Weekly: Ep. 13 –  Cala Health CEO Renee Ryan Brings Business Building Insights to Bioelectronic Medicine Startup

DeviceTalks Weekly: Ep. 13 – Cala Health CEO Renee Ryan Brings Business Building Insights to Bioelectronic Medicine Startup

In this week’s episode of DeviceTalks Weekly, Tom Salemi, editorial director of DeviceTalks events and content, visits with Renee Ryan, the CEO of neuromodulation startup Cala Health.
Ryan came to Cala from the venerable medtech investor Johnson & Johnson Development Corp., where she made over 15 investments helping to create companies including Auris Surgical, Cala and digital surgery play Verb Surgical, J&J’s joint venture with Verily. “I really set my mind to was there a way we could create our own opportunities,” she said of her eight years as the corporate investor.
We ask Ryan about her move into medtech investing from investment banking as well as the “secret power” that helped her succeed as an investor and an executive.
We’ll also discuss the unique commercial strategy Cala is employing as it begins rolling out its Cala Trio, a bioelectronic device developed to treat essential tremor.

  • What role will tech companies play in medtech’s future?
  • Did Verb Surgical meet her expectations?
  • As CEO how do you manage investor syndicates with multiple corporate investors?
  • Can Cala secure reimbursement and create a new market for tremors?
  • What grade did she skip as a child?

Don’t miss an episode! Subscribe to DeviceTalks Weekly on your podcast players.

DTW’s Commencement Speaker – Todd Brinton, MD, Edwards Lifesciences on building a career in medtech

DTW’s Commencement Speaker – Todd Brinton, MD, Edwards Lifesciences on building a career in medtech

In this week’s DeviceTalks Weekly podcast, we attempt to deliver heartfelt and hard won advice in a sort of commencement address by Todd Brinton, MD, Corporate Vice President, Advanced Technology and Chief Scientific Officer of Edwards Lifesciences.

Dr. Brinton sits down with host Tom Salemi to share his path into Medtech. Brinton shares great advice for anyone looking for a new career or opportunity in medtech.

*This interview took place in March

DeviceTalks Weekly: Ep. 11 –  Medtronic is buckling up and ready to buy

DeviceTalks Weekly: Ep. 11 – Medtronic is buckling up and ready to buy

In this week’s DeviceTalks Weekly, we’ll examine how governmental effort, both foreign and domestic, are hitting the medtech industry.

In this week’s episode of DeviceTalks Weekly, we dip into Medtronic’s quarterly call to hear why company executives feel the medtech sector is already rebounding. The global giant also intends to start using its vast cash reserves to bolster its bottomline through M&A.

We’ll also talk with Jeff Champagne of MPR about medtech’s need for speed. He’ll be leading a discussion on this subject and more on the upcoming DeviceTalks Tuesdays.

Don’t miss an episode! Subscribe to DeviceTalks Weekly on your podcast players.

DeviceTalks Weekly: Ep. 10 – How do venture investors make, manage investments going forward?

DeviceTalks Weekly: Ep. 10 – How do venture investors make, manage investments going forward?

In this week’s episode of DeviceTalks Weekly, we talk with venture capital investors about how they’re building and maintaining their medtech portfolios during this pandemic landscape.

Our guests this week are…

  • Justin Klein, MD, managing partner, Vensana Capital
  • Duke Rohlen, chairman, Ajax Health

Together, Klein and Rohlen have created, backed and sold medtech companies that have generated billions.

Klein, formerly of New Enterprise Associates, now co-manages his own venture firm, Vensana Capital. He previously served on the board of directors of Cartiva (acquired), ChromaCode, CV Ingenuity (acquired), EPIX Therapeutics (acquired), FIRE1, GPB Scientific, Intact Vascular, Metavention, Personal Genome Diagnostics, PhaseBio Pharmaceuticals (IPO), Relievant Medsystems, Senseonics (IPO), Topera (acquired), Ulthera (acquired), Vertiflex (acquired), Vesper Medical, and VytronUS (acquired).

Rohlen, who leads a holdings company backed by private equity giant KKR, previously served as chairman and CEO of EPIX, Co-founder, Chairman and CEO of Spirox, Inc (sold to Entellus Medical) and co-founder and CEO of CV Ingenuity. He was also president of Fox Hollow before it was acquired by EV3.

In this podcast we’ll learn how VCs are looking at investment opportunities in this market

  • Are they making new investments?
  • What impact is this having on valuation?
  • Do VCs give stronger consideration to new concerns like supply chain?
  • How are they managing burn rates in their existing portfolio companies?
  • When will they get clinical trials up and running?

Don’t miss an episode! Subscribe to DeviceTalks Weekly on your podcast players.

DeviceTalks Weekly: Ep. 9 – What’s the State of the Medtech Job Market?

DeviceTalks Weekly: Ep. 9 – What’s the State of the Medtech Job Market?

In this week’s episode of DeviceTalks Weekly, Tom Salemi speaks with two executive recruiters about what they see in the medtech market. Over the past month, we’ve seen several medtech companies – big and small – cutting jobs and reducing hours but what does this mean long-term.

In this podcast we’ll identify a few companies that are hiring, but we’ll talk in-depth with the recruiters about…

  • How bad is the current market?
  • What’s the likelihood for recovery?
  • What skills are in greater demand?
  • What can people do to strengthen their hand?

Guests are:

  • David L. Vied, global sector leader, Global Sector Leader, Medical Devices and Diagnostics, Korn Ferry
  • Giovanni Lauricella, vice president, medtech practice-lead, The Mullings Group

Don’t miss an episode! Subscribe to DeviceTalks Weekly on your podcast players.

DeviceTalks Weekly: Ep. 8: AdvaMed‘s Scott Whitaker on pandemic readiness, Jon Norris of SVB shares Q1 venture capital investment data

DeviceTalks Weekly: Ep. 8: AdvaMed‘s Scott Whitaker on pandemic readiness, Jon Norris of SVB shares Q1 venture capital investment data

In this week’s episode of DeviceTalks Weekly, Scott Whitaker, CEO of AdvaMed, shares concerns he had over how the federal government would work with the medtech industry during the pandemic crisis. Does he feel the medtech industry was treated fairly? How does he see the federal government and medtech industry working together in the future? He answers those questions and more.
In our second interview, Jonathan Norris, managing director of Silicon Valley Bank, shares first-quarter data for medtech venture investments. The results might surprise you.
Guests are:

  • Scott Whitaker, CEO, AdvaMed
  • Jonathan Norris, managing director, Silicon Valley bank

DeviceTalks Weekly: Ep. 7 – Edwards, Employment News, Update on Clinical Trials from Avania

DeviceTalks Weekly: Ep. 7 – Edwards, Employment News, Update on Clinical Trials from Avania

In this week’s episode of DeviceTalks Weekly, Tom Salemi and Chris Newmarker stare at each other through the Zoom lens while talking about the positive employment news from Baxter International and Conformis, the hopeful news from Edwards Lifesciences, and the cautionary tone from Medtronic. What can we expect from the rest of medtech?

In the first half of the podcast, we examine comments from Edwards’ Q1 call. The company is warning analysts about a rough second quarter but explains why the situation may improve in the second half of the year.
For a look at the state of clinical trials in medtech, we talk with Mark McIlduff, general manager, U.S., at the newly named CRO, Avania. McIlduff walks us through how clinical trials were shut down by the Covid-19 crisis and what it might take to get them started in the future.

DeviceTalks Weekly: Ep. 6 – Hear about the Coventor ventilator, Q1 earnings and MassDevice’s Medtech 100 Index

DeviceTalks Weekly: Ep. 6 – Hear about the Coventor ventilator, Q1 earnings and MassDevice’s Medtech 100 Index

In this week’s episode of DeviceTalks Weekly, Aaron Tucker of the Earl Bakken Medical Center shares the origin of the recently approved Coventor ventilator, which will be manufactured at-cost by Boston Scientific.

We’ll also hear comments Abbott CEO Robert Ford made during the company’s Q1 analyst call as the MassDevice team begins to dissect how the COVID-19 pandemic will impact medtech earnings.

Finally, Danielle Kirsh, senior editor at WTWH Media, will share the origins of our new MedTech 100 Index, a powerful new tool for measuring how large medtech companies are managing in this new economy.

Guests are:

  • Aaron Tucker, Lab Supervisor, University of Minnesota Earl E. Bakken Medical Device Center
  • Danielle Kirsh, Senior Editor, WTWH Media

DeviceTalks Weekly: Ep. 5 – How can startups move forward during a pandemic?

DeviceTalks Weekly: Ep. 5 – How can startups move forward during a pandemic?

Raising capital for startup is never easy. Try doing it during a pandemic.

In this week’s DeviceTalks Weekly, we’ll try to help entrepreneurs by talking with two guests who are committed to helping startups find the funding they need.

Paul Grand, founder and CEO of MedTech Innovator, explains how he’s working to keep startups connected to capital. His popular MedTech Innovator program is adapting to the times and creating new ways for startups to get in front of investors.

We’ll also talk with Shai Policker, CEO at MEDX Xcelerator, an incubator backed by Boston Scientific, Intellectual Ventures and others. Based in Israel, MEDX is moving forward and interested in investing capital in start-ups worldwide.

Both give advice to fund-raising entrepreneurs and offer some helpful resources.

Co-host Chris Newmarker, executive editor, life sciences, for WTWH Media, also reviews the latest in COVID-19 news on MassDevice and Medical Design and Outsourcing.

Don’t miss an episode! Subscribe to DeviceTalks Weekly on your podcast players.

DeviceTalks Weekly: Ep.4 — What does Medtronic’s Puritan reveal mean for medtech?

DeviceTalks Weekly: Ep.4 — What does Medtronic’s Puritan reveal mean for medtech?

What does Medtronic’s Puritan reveal mean for medtech?

Medtronic earned plaudits and praise for sharing the design specifications for its Puritan Bennett 560 (PB560) ventilators. But will the gesture actually lead to more ventilators being manufactured?

In this episode of DeviceTalks Weekly, we’ll talk with experts who will tell us what the plans do and do not say. We’ll also get some legal insights on what strings are attached to the open-source effort.

Guests are:

  • D. Brian Kacedon, partner, Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
  • Lee Teschler, executive editor, WTWH Media
  • Scott Thielman, CTO, Product Creation Studio

Don’t miss an episode! Subscribe to DeviceTalks Weekly on your podcast players.

DeviceTalks Weekly Podcast: Deconstructing medtech’s alphabet soup – DPA, MDR, FDA are all in the news

DeviceTalks Weekly Podcast: Deconstructing medtech’s alphabet soup – DPA, MDR, FDA are all in the news

In this week’s DeviceTalks Weekly, we’ll examine how governmental effort, both foreign and domestic, are hitting the medtech industry.

Our guests include Tracy Eberly, CEO of Fang Consulting, a regulatory advisory group. Eberly will update listeners on what pushing back the MDR deadline could mean for medtech companies and why some companies may be less than thrilled with the decision.

In our second conversation, Joy Sturm, procurement expert and partner at the DC office of Law Firm Hogan Lovells, walks us through the powers contained within the Defense Production Act (DPA) invoked last week by the Trump administration.

Sturm, who brings 20 years of governmental purchasing experience to the conversation, answer several key questions including:

  • What CAN and CAN’T the government do under the act?
  • Which federal agencies are responsible for executing the DPA?
  • Can companies secure capital to pay for DPA-supported efforts?
  • What player is missing on the field in the battle against COVID-19?

Also, Advamed is also looking for direction from the Federal government. You may be surprised by the potential source of leadership.

Finally, MassDevice honcho Chris Newmarker talks DYI ventilators. Check out Mass Device’s Sean Whooley’s feature here.  And what does the FDA say about these projects?

DeviceTalks Weekly: Medtech goes to war with COVID-19

DeviceTalks Weekly: Medtech goes to war with COVID-19

In this week’s DeviceTalks Weekly Podcast, we’ll talk about medtech’s essential role in the escalating war against COVID-19.

We’ll visit with Fluidda CEO Jan De Backer and Kevin Thornal, division president of diagnostic solutions at Hologic. The executives will explain how their imaging and diagnostic devices – which both received recent FDA approval –  will aid against the diagnosis and treatment of COVID-19. 

We’ll also discuss how these two medtech executives view the Trump Administration’s invoking of the Defense Production Act, a Korean-war era law that could have unseen impacts on medtech companies and their supply chain.

DeviceTalks Weekly is hosted by Tom Salemi, editorial director, DeviceTalks, and Chris Newmarker, executive editor, life sciences.

DeviceTalks Weekly: How is coronavirus affecting medtech?

DeviceTalks Weekly: How is coronavirus affecting medtech?

Welcome to the DeviceTalks Weekly podcast, a regular – and sometimes irregular – opportunity to visit with the editorial team at MassDevice and Medical Design & Outsourcing.

This week, Chris Newmarker, executive editor, life sciences, at WTWH Media, reviews our COVID-19 coverage with Tom Salemi, editorial director, DeviceTalks. Tom also chats with Jeffries analyst Raj Denhoy, who details how the medtech sector is faring in this unprecedented uncertainty.

While most medtech companies stand on strong financial footing, Denhoy issues a warning to investors that another correction may be coming once analysts start assessing the impact on earnings. Still, he says there are safe havens out there and identifies one in the podcast. Finally, Tom and Chris explore what impact social distancing may have on medtech in the short-term – sales and deals – and long-term – innovation.

Experts explore the state of M&A in medtech

Experts explore the state of M&A in medtech

At DeviceTalks West 2018, a panel of experts gathered to discuss the state of M&A in medtech and the forces driving startups to seek an exit. Read more >>

Prioritizing Innovation – How major players in medtech stay ahead of the curve

Prioritizing Innovation – How major players in medtech stay ahead of the curve

In the medtech industry, if you don’t innovate, you can’t compete. Read more >>

What should the Mann Foundation do next?

What should the Mann Foundation do next?

Dr. Robert Greenberg, the Mann Foundation’s new executive chairman, has ideas about where to take one of medtech’s top research and development outfits. He explained more at DeviceTalks West in December. Read more >>

Diabetes tech execs talk patient-centric design, device development & trust

Diabetes tech execs talk patient-centric design, device development & trust

John Timberlake has been commercializing diabetes drugs and devices for 25 years. Over the course of his career, one theme has always stood out: if you want people to use your product, it has to be made with the end-user in mind. Read more >>

Here’s how Intuitive Surgical is innovating to stay competitive

Here’s how Intuitive Surgical is innovating to stay competitive

Intuitive Surgical isn’t resting on its laurels when it comes to the surgical robotics field that it dominates. The Sunnyvale, Calif.­–based company is seeking to stay competitive through technologies including computer-controlled navigated robotic catheters, contrast agents to improve imaging during procedures, and intelligent surgical interfaces. Read more >>

How Reggie Groves reinvented Medtronic’s atrial fibrillation biz

How Reggie Groves reinvented Medtronic’s atrial fibrillation biz

Reva Medical CEO Reggie Groves got her start in the medical device industry at medtech titan Medtronic. In her upcoming keynote interview at DeviceTalks West, Groves will discuss how that experience has shaped her as a leader and an innovator. Here’s a preview. Read more >>

Alfred Mann Foundation chairman looks outward to extend founder’s legacy

Alfred Mann Foundation chairman looks outward to extend founder’s legacy

When medtech pioneer Alfred Mann died in February 2016, he left behind a rich legacy of pure innovation and patient impact spanning the breadth of healthcare, from cardiology to hearing impairment, blindness and diabetes that will improve the lives of patients for decades to come. Read more >>

How a teenage Gary Guthart, Intuitive Surgical’s CEO, got his start at NASA

How a teenage Gary Guthart, Intuitive Surgical’s CEO, got his start at NASA

Today Gary Guthart is best known as the CEO of Intuitive Surgical, the world’s leading medical robotics company. But robot-assisted surgery wasn’t Guthart’s first love, he told MassDevice.com ahead of his keynote appearance at this year’s DeviceTalks West event. Read more >>

Here’s the view from the top at Hologic

Here’s the view from the top at Hologic

Steve MacMillan took over as CEO of Hologic in 2013, drawing on his experience at medtech titans like Stryker and Johnson & Johnson. Read more >>

DeviceTalks Boston: 5 medtech startups you need to know

DeviceTalks Boston: 5 medtech startups you need to know

Steve MacMillan took over as CEO of Hologic in 2013, drawing on his experience at medtech titans like Stryker and Johnson & Johnson. Read more >>

DeviceTalks: Hologic CEO MacMillan on leading a turnaround and the importance of women’s health in medtech

DeviceTalks: Hologic CEO MacMillan on leading a turnaround and the importance of women’s health in medtech

Stephen MacMillan joined a struggling Hologic as CEO in December 2013, and within one day, he had already made his first major move in restructuring the company’s executive leadership team. Read more >>

7 medtech ideas out of Europe

7 medtech ideas out of Europe

Mobile and digital health ideas — and overall medtech innovation ideas — abound in Europe, with DeviceTalks Boston attendees getting just a sampling this morning from seven CRAASH Barcelona participants. Read more >>

When product development goes sideways (and how to fix it)

When product development goes sideways (and how to fix it)

We would all like for product development projects to go smoothly and predictably, but you know what they say about “the best-laid plans.” Robert Burns aside, when needed technologies do not integrate as easily as planned, hardware or software bugs crop up at the last minute (or worse, cause failures in the field), or project teams struggle to complete work on schedule, forward progress is stalled. Fixed costs stay the same but time to launch date deadlines are compressed. This is only one example of when things go sideways. Read more >>

How strong patent portfolios attract strategic investments and deals

How strong patent portfolios attract strategic investments and deals

The medical device industry has demonstrated strong and sustainable growth in recent years. Given the aging population, increasing incidence of chronic and lifestyle diseases, emergence of artificial intelligence (AI) and big data, and significant investments in R&D and M&A, the medtech sector appears to be in prime health. According to KPMG, the medical device industry’s global annual sales are forecast to rise more than 5% a year to reach nearly $800 billion by 2030. As the industry evolves, medtech companies are making strategic moves to stay ahead in their respective markets. Read more >>

Lessons learned: How Jeff Karp stays at the forefront of innovation

Lessons learned: How Jeff Karp stays at the forefront of innovation

Serial entrepreneur Jeff Karp has a philosophy for his laboratory: find important problems and get solutions to people quickly. Read more >>

The future of Abbott’s electrophysiology business

The future of Abbott’s electrophysiology business

At DeviceTalks Minnesota 2018, medtech veteran Michael Pederson provided an inside look at the Abbott-St. Jude Medical merger and what’s ahead for Abbott’s cardiovascular technologies. Read more >>

How Intuitive Surgical’s robotic systems are changing surgery

How Intuitive Surgical’s robotic systems are changing surgery

Robots are making their way into operating rooms around the world, acting as extensions of the surgeon. Intuitive Surgical, a mainstay in the robotic-assisted surgery field, has positioned its technologies as helping surgeons boost their performance and offer minimally-invasive options to patients. Read more >>

How Bigfoot Biomedical’s CEO wants to boost diabetes management

How Bigfoot Biomedical’s CEO wants to boost diabetes management

Jeffrey Brewer faced the biggest challenge of his life when his 7-year-old son Sean received a diabetes diagnosis in 2002: Diabetes became the new focus for Brewer’s energy. Read more >>

Speakers you need to see at DeviceTalks Minnesota

Speakers you need to see at DeviceTalks Minnesota

A Google executive whose own heart problems spurred her to seek medtech innovation, a leader at Abbott who wants to drive healthcare value, the head of an upstart company seeking to transform diabetes care — those are but some of the speakers you will encounter at DeviceTalks Minnesota this June. Read more >>

All heart: A Google executive’s real-world experience with medtech

All heart: A Google executive’s real-world experience with medtech

After hearing the story of her 10 cardiac surgeries and seven pacemakers, you could be forgiven for thinking that Heidi Dohse has a weak heart. But the Google executive, endurance cyclist and, now, inspirational speaker she may have a stronger heart than most people on the planet. Read more >>

7 ways you can doom your medical device startup

7 ways you can doom your medical device startup

Randy Nelson has worked with medical device startups for more than a dozen years through his Evergreen Medical Technologies (St. Paul, Minn.), as well as the University of Minnesota’s Carlson School of Management. Read more >>

For this Abbott executive, solving problems isn’t enough: ‘We need to add value’

For this Abbott executive, solving problems isn’t enough: ‘We need to add value’

As payers and providers across healthcare shift their focus to value-based care, leaders in the medical device industry are racing to keep up. Michael Pederson, SVP of cardiac arrhythmias and heart failure at Abbott, told MassDevice.com why simply solving problems with new technology isn’t enough anymore, learn here. Read more >>

Stroke treatment: There’s a simple way to improve it in the U.S.

Stroke treatment: There’s a simple way to improve it in the U.S.

Technology is already available to greatly improve outcomes for people suffering from strokes, but the present healthcare system is standing in the way of people getting it, according to Stacey Pugh, VP and general manager of the neurovascular unit at Medtronic. Read more >>

DeviceTalks West: Here are the speakers you’ll see

DeviceTalks West: Here are the speakers you’ll see

Hundreds of medical device industry insiders are expected to descend on Orange County, Calif., this month for DeviceTalks West – a premier boutique networking and learning event. Read more >>

DeviceTalks: 3M’s Cindy Kent on leadership, growth and inclusion in medtech

DeviceTalks: 3M’s Cindy Kent on leadership, growth and inclusion in medtech

Cindy Kent is no stranger to medtech – she’s spent 20 years in healthcare, moving up the ranks and finding her way to president & GM for 3M’s infection prevention division. She spoke with MassDevice.com Publisher Brian Johnson at the DeviceTalks event in Minnesota this week about her skills as a leader, how she ended up as an ordained minister and the importance of inclusion and mentorship in the workplace. Read more >>